Real-World Risk of Gastrointestinal Bleeding for Direct Oral Anticoagulants and Warfarin Users: A Distributed Network Analysis Using a Common Data Model.

Jae Myung Cha Myoungsuk Kim Hyeong Ho Jo Won-Woo Seo Sang Youl Rhee Ji-Hyun Kim Gwang Ha Kim Junseok Park

Published in: Gut and liver (2024)

: In real-world practice, the risk of GIB in new DOAC users is comparable to that in new warfarin users. In DOAC users, the risk of GIB was lower in edoxaban or apixaban subgroups than rivaroxaban or dabigatran subgroups.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
network analysis
healthcare
oral anticoagulants
primary care
electronic health record
big data
deep learning
machine learning